Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof inventions 12/07

20070299244 - Liposome allowing liposome-entrapped substance to escape from endosome: With the aim of providing a liposome, having a hydrophilic polymer introduced into the outer surface of the liposome membrane, which is a liposome capable of allowing the liposome-entrapped substance to escape from the endosome and be released into the cytoplasm, a liposome membrane component bound to the peptide shown... Agent: Lahive & Cockfield, LLP

20070299245 - P277 peptide formulations or variants thereof having optimized stability: The invention relates to formulations containing the peptide p277 or variants thereof which are characterized by having increased stability during storage and transport.... Agent: Andrea Q. Ryan Sanofi-aventis U.s. LLC

20070299246 - In vitro protein expression process comprising ckappa fusion molecules: The invention relates to an in vitro protein expression process comprising preparation of a nucleic acid molecule which comprises a fusion of a gene encoding a target protein and a gene encoding an immunoglobulin κ light chain constant domain (Cκ) followed by cell-free protein expression. The invention also relates to... Agent: Howrey LLP

20070299247 - Human cytokine receptor: Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor16.”... Agent: Zymogenetics, Inc. Intellectual Property Department

20070299248 - Calcium phosphate cements comprising an osteoclastogenic agent: Methods and compositions are provided for producing flowable compositions, e.g. pastes, that set into calcium phosphate products that include an osteoclastogenic agent. In the subject methods, dry reactants that include a calcium source and a phosphate source are combined with a setting fluid and an osteoclastogenic agent, e.g., RANKL or... Agent: Bozicevic, Field & Francis LLP

20070299249 - Polymer particles: A process for covalently binding a tagged protein to a polymer particle comprising: contacting a tagged protein with a chelating agent-polymer particle conjugate wherein said tag comprises at least two histidine residues and at least two lysine residues and said chelating agent is tridentate, tetradentate or pentadentate and comprises at... Agent: Invitrogen Corporation C/o Intellevate

20070299250 - Production of a von willebrand factor preparation using hydroxylapatite: This invention relates to a process for the production of a von Willebrand factor preparation, hydroxylapatite being used as a chromatography medium.... Agent: Smith Patent Consulting Consulting, LLC

20070299251 - Isolation of plasma or serum proteins: The present invention provides a process for the isolation of one or more proteins) from a protein solution. The process comprising the steps of: a) providing a protein solution comprising one or more specific proteins) and having a preset pH and a preset ionic strength or conductivity, b) applying the... Agent: Foley And Lardner LLP Suite 500

20070293655 - Supercritical fluids processing: preparation of protein microparticles and their stabilisation: A coprecipitate of protein or polypeptide and stabiliser obtained by a process for the co-precipitation of a substance with a stabiliser therefor, by a gas anti solvent process comprising introducing into a particle formation vessel a supercritical fluid pure or mixed with a modifier; and a solution comprising said substance... Agent: Needle & Rosenberg, P.C.

20070293656 - Collagen binding peptides: Peptides capable of binding to extracellular matrix proteins, such as collagen, are described, including their use in diagnostic and therapeutic applications.... Agent: Fish & Richardson P.C.

20070293657 - Complexes and methods of forming complexes of ribonucleic acids and peptides: A complex of a double stranded (ds) ribonucleic acid and a peptide produced by a method comprising dissolving the nucleic acid in an aqueous solution, dissolving the peptide in an aqueous solution, mixing the solubilized ds nucleic acid and the solubilized peptide, and treating the mixture by freezing and thawing,... Agent: Nastech Pharmaceutical Company Inc

20070293658 - Process for the purification of il-18 binding protein: The invention relates to a process for the purification of IL-18 binding protein (IL-18BP) from a fluid using aqueous two-phase partitioning.... Agent: Saliwanchik Lloyd & Saliwanchik A Professional Association

20070293659 - Immobilization of glycoproteins: Methods and compositions for the immobilization of glycoproteins are presented herein. In addition, the present invention provides arrays of immobilized glycoproteins. The methods of immobilizing glycoproteins include oxidation of the glycosyl moiety.... Agent: Townsend And Townsend And Crew, LLP

20070293660 - Method for purifying granulocyte-colony stimulating factor: The present invention provides a novel process for isolating and purifying rmetHuG-CSF from a G-CSF producing microorganism. The invention also relates to a method of improved over-expression of G-CSF in E. coli., a primer sequence for amplification of a modified hG-CSF sequence, plasmids, expression vestors and host cells for use... Agent: Cooper & Dunham, LLP

20070287825 - Constrained cis-diol-borate bioconjugation system: The invention pertains to bioconjugation systems comprising sterically constrained cis-diols and borates.... Agent: Hamilton, Brook, Smith & Reynolds, P.C.

20070287826 - Production of high molecular mass lectins: The invention relates to a process for preparing a high molecular weight lectin composition, in particular comprising the mannose-binding lectin (MBL). In one aspect there is provided a method for producing a composition comprising a variety of lectin molecules, wherein substantially all of said lectin molecules have a high molecular... Agent: Browdy And Neimark, P.l.l.c. 624 Ninth Street, Nw

20070287827 - Method for the purification of an n-terminal fragment of hepatocyte growth factor: A method for the production of the N-terminal four kringle-containing fragment of hepatocyte growth factor (NK4) by expression of a nucleic acid encoding said NK4 in a microbial host cell, isolation of inclusion bodies containing said NK4 in denatured form, solubilization of the inclusion bodies and naturation of the denatured... Agent: Hoffmann-la Roche Inc. Patent Law Department

20070287828 - Compositions and methods for the reversible capture of biomolecules: Substrates (e.g., polymer), and/or solid supports (e.g., glass) having one or more biomolecule-binding compounds covalently bound to the surface of the substrate or solid support reversible covalent attachment of biomolecules thereto.... Agent: Christine R Ethridge Kirkpatrick & Lockhart Nicholson Graham

20070282095 - Thrombin derivatives and medicinal composition containing the same: The present invention provides a thrombin derivative, comprising an A chain and a B chain, the B chain having an amino acid sequence in which one or more kinds of active center amino acids selected from the group consisting of serine at position 205, glycine at position 203, aspartic acid... Agent: J C Patents, Inc.